- Vienna '18
- ESCRS Player
- On Demand
- ESCRS iLearn
- ESCRS YO's
First Author: JosefReiter GERMANY
Back to previous
Clinical evaluation of this new MIOL with progressive near-addition in the inferior IOL-segment, performing a prospective study in the context of planed cataract surgery. Focus of investigation was subjective tolerance, photic phenomena, post op visual acuity for far, near and intermediate and overall patient satisfaction.
: Eye-Clinic Landshut, Bavaria
From July to October 2013 22 eyes of 15 patients (unilateral and bilateral) received the above MIOL MF20 in the context of planed cataract surgery. All eyes were otherwise healthy, with the exception of mild AMD and/or glaucoma. The clinically expected post op visual acuity was 0.6 or above. 4 to 6 weeks post op eyes were examined for data-collection and statistical analysis.
As expected there was a significant improvement of BSCVA from pre op 0.38 to post op 0.64 (mean). Post op spherical equivalent (SE) was -0.21 dpt. Most patients achieved spectacles independence in everyday life, with the exception of very small print (UNVA < 0.8). Average UDVA was 0.70, UIVA was 0.63 and UNVA was 0.52. CDVA was 0.84, CIVA was 0.68 and CNVA was 0.65. All eyes were above 0.50 corrected and uncorrected for all distances. Monocular maximum accepted near-addition was reduced to +1.25 dpt. The additional near visual acuity was the main reason for overall very high patient satisfaction. Optical side effects like halos, glare, problems with night-driving or other photic phenomena were not reported spontaneously by any patient, 4 patients reported on early night driving problems on request.
In this prospective study with implantation of the new Lentis LS-313 MF20 almost all patients achieved spectacles-independence in everyday life, except reading very fine print. Average near visual acuity was above 0.50, uncorrected and distance-corrected. Overall patient satisfaction was very high. No optical side effects were reported spontaneously. FINANCIAL INTEREST: NONE